CTRI/2023/07/055131尚未招募4 期
â??Treatment adherence, tolerability and safety of Ayurveda therapeutic regimen in the management of Primary Knee Osteoarthritis: An OPD-based study
Central council for research in ayurvedic science0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 American College of Rheumatology (ACR) functional status criteria class I, II and III
- •2 Able and willing to give informed consent
排除标准
- •EXCLUSION CRITERIA
- •Patients with the following criteria will be excluded from the study:
- •Grade 3 and above radiographic changes in the affected knee (Kellgren-Lawrence classification)
- •Significant trauma to the knee including arthroscopy within preceding one year
- •History of knee joint replacement
- •BMI>=30 kg/m²
- •History of prior intra-articular corticosteroid or hyaluronic acidadministration within one month of the study
- •Patient taking corticosteroids
- •Patient with history of Rheumatoid arthritis, Psoriatic arthritis, Psoriatic arthritis, or any other type of inflammatory arthritis
- •History of hepatic disorders (more than three times upper normal limit of normal of liver enzymes) or renal disorders (serum creatinine > 1.2 mg%)
- •History or active malignancy
- •Hypersensitivity to study interventions
- •Any other disease condition that in the opinion of the investigator may compromise the participantâ??s safety or compliance
研究者
相似试验
招募中
3 期
Clinical study of Ayurvedic intervention – Punarnavadi Mandura in treating Iron Deficiency Anemia.CTRI/2023/05/053299CENTRAL COUNCIL FOR RESEARCH IN AYURVEDIC SCIENCES Ministry of AYUSH
尚未招募
3 期
Management of Rheumatoid Arthritis Through Ayurveda InterventioCTRI/2023/04/051829CENTRAL COUNCIL FOR RESEARCH IN AYURVEDA SCIENCES
尚未招募
3 期
OPD-based trial for Treatment adherence, tolerability and safety of Ayurveda therapeutic regimen in the management of Primary Knee OsteoarthritisCTRI/2023/07/054948Central Council for Research in Ayurvedic Sciences
尚未招募
3 期
Clinical Study to assess the Tolerability, Treatment adherence, and safety of Drakshavaleha in Iron Deficiency AnemiaCTRI/2023/07/055315Central Council for Research in Ayurvedic Sciences
进行中(未招募)
1 期
An open-label, long-term, safety and tolerability study of SAR445088 in participants with cold agglutinin disease previously treated with SAR445088 or never treated with SAR445088Autoimmune haemolytic anaemiaMedDRA version: 20.0Level: PTClassification code: 10073785Term: Autoimmune haemolytic anaemia Class: 100000004851CTIS2023-510210-68-00Bioverativ USA Inc.18
